While combination antiretroviral therapy has made a huge difference in treatment of HIV, many people living with HIV are still undiagnosed or diagnosed late. This is especially true of incarcerated people, who, due to factors like poverty or homelessness, may not have access to health care. Further expansion in HIV treatment options, incorporating women-centered approaches, is essential to make individualized care a reality. With longer life expectancies, people living with HIV are at increased risk of developing non-AIDS comorbidities, such as cardiovascular diseases and cancers. Antiretroviral strategies are evolving toward a decrease in drug burden, and some two-drug combinations have proven efficacy for maintenance therapy. Investigational immune checkpoint inhibitors and broadly neutralizing antibodies with effector functions have energized the HIV cure research field as the search for an effective vaccine continues. This session will discuss the latest treatments for HIV, developing individualized care, and non-AIDS comorbidities.

Learning objectives:

• Discuss the use of combination antiretroviral therapy to treat HIV
• Explain the elements needed to develop individualized care programs and special issues faced by female patients
• Identify non-AIDS comorbidities that people living with HIV may develop